Get the Stockscreener App
8.44
4.20%
0.34
After Hours:
8.44
Elanco Animal Health Inc stock is traded at $8.44, with a volume of 5.20M.
It is up +4.20% in the last 24 hours and down -20.68% over the past month.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$8.10
Open:
$8.1
24h Volume:
5.20M
Relative Volume:
1.07
Market Cap:
$4.31B
Revenue:
$4.45B
Net Income/Loss:
$205.00M
P/E Ratio:
21.10
EPS:
0.4
Net Cash Flow:
$372.00M
1W Performance:
-3.10%
1M Performance:
-20.68%
6M Performance:
-34.22%
1Y Performance:
-37.06%
1-Day Range:
$8.02
$8.46
1-Week Range:
$8.02
$8.85
52-Week Range:
$8.02
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Name
Elanco Animal Health Inc
Sector
Phone
877-352-6261
Address
2500 INNOVATION WAY, GREENFIELD
Compare ELAN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
8.44 | 4.31B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
148.66 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.22 | 45.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.65 | 15.60B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.73 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Initiated | UBS | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Market Perform |
| Sep-19-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-19-23 | Initiated | Jefferies | Buy |
| Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Apr-20-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-18-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-16-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Sell |
| Jul-12-22 | Initiated | Piper Sandler | Neutral |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Oct-28-21 | Downgrade | Stifel | Buy → Hold |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jun-15-21 | Upgrade | Cleveland Research | Underperform → Neutral |
| May-11-21 | Upgrade | Barclays | Underweight → Equal Weight |
| May-11-21 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-15-21 | Initiated | Stifel | Buy |
| Mar-22-21 | Downgrade | Gabelli & Co | Buy → Hold |
| Feb-26-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-09-20 | Downgrade | Argus | Buy → Hold |
| Nov-09-20 | Downgrade | Barclays | Overweight → Underweight |
| Aug-20-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-13-20 | Resumed | Credit Suisse | Neutral |
| Aug-04-20 | Resumed | Goldman | Buy |
| Jul-27-20 | Downgrade | Cleveland Research | Neutral → Underperform |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Dec-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-07-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-19 | Initiated | Barclays | Overweight |
| Aug-26-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-15-19 | Upgrade | UBS | Sell → Neutral |
| May-23-19 | Initiated | Guggenheim | Neutral |
| Mar-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-13-19 | Resumed | Morgan Stanley | Equal-Weight |
| Feb-12-19 | Initiated | William Blair | Mkt Perform |
| Jan-23-19 | Initiated | UBS | Sell |
| Jan-15-19 | Initiated | Argus | Buy |
| Oct-15-18 | Initiated | Morgan Stanley | Equal-Weight |
View All
Elanco Animal Health Inc Stock (ELAN) Latest News
Middle East And Africa Animal Healthcare Market Generated - openPR.com
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Alliancebernstein L.P. - Defense World
LPL Financial LLC Raises Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Connect - markets.businessinsider.com
Veterinary Medicine Market to Witness Remarkable Growth with Ceva, Zoetis, Elanco, Chanelle Pharma Group - openPR.com
Elanco (ELAN) Sees Price Target Cut by Morgan Stanley to $10 | ELAN Stock News - GuruFocus
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL.com
Elanco Animal Health (NYSE:ELAN) Given New $13.00 Price Target at Stifel Nicolaus - Defense World
Stifel Adjusts Elanco (ELAN) Price Target, Maintains Buy Rating - GuruFocus
Franklin Resources Inc. Has $1.87 Million Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
‘Let the bad news travel as fast as the good news’: 5 questions for Elanco Animal Health’s Jeff Simmons - Semafor
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Stockholders to Learn More About the Investigation - markets.businessinsider.com
Elanco Animal Health (ELAN) Soars 12.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Companion Animal Vaccine Marketto Register for Rapid Growth, - openPR.com
Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement | ELAN Stock News - GuruFocus
Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement - Nasdaq
Pets External Medicine Market Still Has Room To Grow: Zoetis, Elanco, Merck Animal Health, Bayer Animal Health - openPR.com
American Century Companies Inc. Acquires 2,280 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco enters research agreement to address CKD in cats and explore lifespan extension in pets - DVM360
Veterinary Oncology Market Is Booming Worldwide 2025-2032 | - openPR.com
Commonwealth Equity Services LLC Sells 9,801 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Investors to Inquire about Securities Investigation - markets.businessinsider.com
Elanco Partners With SASH To Support Blood Donor Program - ACCESS Newswire
2025-04-08 | Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Investors to Inquire about Securities Investigation | NYSE:ELAN | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Reach Out - ACCESS Newswire
HighTower Advisors LLC Reduces Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco Expands Huningue Site to Support Latest Pet Health Innovations - ACCESS Newswire
Elanco Breaks Ground for Animal Health in Huningue, France - 3BL Media
Veterinary Clostridium Vaccine Market Detailed Industry - openPR.com
Dogs Vaccines Market Generated Opportunities, Future Scope - openPR.com
ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Examination into Elanco Animal Health Incorporated and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com
Elanco stock hits 52-week low at $10.02 amid market challenges - Investing.com
Veterinary Oncology Market Future Business Opportunities - openPR.com
FDA Approval of Elanco Cow Ammonia Drug Upheld in Federal Court - Bloomberg Law News
ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Shareholders of Elanco Animal Health Incorporated Should Contact Levi & Korsinsky Before December 6, 2024 to Discuss Your RightsELAN - ACCESS Newswire
ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
FDA Beats Challenge To Approval Of Elanco's Cattle Gas Drug - Law360
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Elanco wins dismissal of Tevra Brands' US antitrust complaint - MLex
Elanco Animal Health: Even Cheaper, Still Not A Buy - Seeking Alpha
Dogs Vaccines Market Size, Industry Shares, Global Growth - openPR.com
Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Shareholders to Inquire about Securities Investigation - markets.businessinsider.com
Corient Private Wealth LLC Decreases Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Is Elanco Animal Health (ELAN) About to Explode? - Yahoo Finance
Thrivent Financial for Lutherans Sells 310,108 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - The AM Reporter
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect - Markets Insider
Elanco Animal Health Inc Stock (ELAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Elanco Animal Health Inc Stock (ELAN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Kurzius Lawrence Erik | Director |
Mar 11 '25 |
Buy |
10.20 |
10,000 |
102,000 |
111,459 |
| HOOVER R DAVID | Director |
Mar 05 '25 |
Buy |
10.90 |
25,000 |
272,558 |
210,000 |
| Harrington Michael J | Director |
Aug 22 '24 |
Buy |
14.85 |
3,500 |
51,974 |
81,094 |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR |
Aug 12 '24 |
Buy |
13.01 |
100,000 |
1,300,610 |
145,000 |
| DOYLE WILLIAM F | Director |
May 21 '24 |
Buy |
16.98 |
15,000 |
254,700 |
76,330 |
0.66%
1.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):